| 1 |
Tognetti L, Fiorani D, Russo F, Lazzeri L, Trovato E, Flori ML, Moscarella E, Cinotti E, Rubegni P. Teledermatology in 2020: past, present and future perspectives. Ital J Dermatol Venerol 2021;156:198-212. [PMID: 33960751 DOI: 10.23736/S2784-8671.21.06731-6] [Reference Citation Analysis]
|
| 2 |
Emerick T, Alter B, Jarquin S, Brancolini S, Bernstein C, Luong K, Morrisseyand S, Wasan A. Telemedicine for Chronic Pain in the COVID-19 Era and Beyond. Pain Med 2020;21:1743-8. [PMID: 32914858 DOI: 10.1093/pm/pnaa220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 3 |
Choi E, Mak WK, Law JY, Santos D, Quek SC. Optimizing teledermatology: looking beyond the COVID-19 pandemic. Int J Dermatol 2021;60:119-21. [PMID: 33128455 DOI: 10.1111/ijd.15272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Emerick T, Alter B, Jarquin S, Brancolini S, Bernstein C, Luong K, Morrisseyand S, Wasan A. Telemedicine for Chronic Pain in the COVID-19 Era and Beyond. Pain Med 2020;21:1743-8. [PMID: 32914858 DOI: 10.1093/pm/pnaa220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 5 |
Thomas EE, Haydon HM, Mehrotra A, Caffery LJ, Snoswell CL, Banbury A, Smith AC. Building on the momentum: Sustaining telehealth beyond COVID-19. J Telemed Telecare. [DOI: 10.1177/1357633x20960638] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 6 |
Abbott LM, Miller R, Janda M, Bennett H, Taylor M, Arnold C, Shumack S, Soyer HP, Caffery LJ. Practice guidelines for teledermatology in Australia. Australas J Dermatol 2020;61:e293-302. [PMID: 32363572 DOI: 10.1111/ajd.13301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Deda LC, Goldberg RH, Jamerson TA, Lee I, Tejasvi T. Dermoscopy practice guidelines for use in telemedicine. NPJ Digit Med 2022;5:55. [PMID: 35477979 DOI: 10.1038/s41746-022-00587-9] [Reference Citation Analysis]
|
| 8 |
Wang C, Rademaker M, Baker C, Foley P. COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement. Australas J Dermatol 2020;61:210-6. [PMID: 32255510 DOI: 10.1111/ajd.13313] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 9 |
Cinelli E, Megna M, Di Guida A, Greco V, Annunziata MC, Fabbrocini G. Teledermatology for patient management, dermatology education and research during the COVID-19 pandemic. Australas J Dermatol 2020;61:e471-2. [PMID: 32410218 DOI: 10.1111/ajd.13345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
